DF Dent & Co. Inc. Has $17.04 Million Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

DF Dent & Co. Inc. cut its stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 3.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 353,434 shares of the financial services provider's stock after selling 14,437 shares during the period. DF Dent & Co. Inc. owned approximately 0.83% of Trupanion worth $17,036,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. SBI Securities Co. Ltd. acquired a new stake in shares of Trupanion in the fourth quarter valued at $25,000. Jones Financial Companies Lllp raised its position in Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock worth $27,000 after acquiring an additional 238 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Trupanion in the 3rd quarter valued at about $54,000. KBC Group NV bought a new position in shares of Trupanion during the 4th quarter valued at about $75,000. Finally, R Squared Ltd bought a new stake in shares of Trupanion in the 4th quarter worth approximately $79,000.

Insiders Place Their Bets

In other Trupanion news, insider Brenna Mcgibney sold 5,000 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $164,950.00. Following the completion of the sale, the insider now owns 3,738 shares of the company's stock, valued at $123,316.62. This represents a 57.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Emily Dreyer sold 14,025 shares of Trupanion stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the transaction, the senior vice president now directly owns 27,645 shares in the company, valued at approximately $895,974.45. This represents a 33.66 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 29,792 shares of company stock valued at $989,442 over the last quarter. Insiders own 5.50% of the company's stock.

Remove Ads

Trupanion Stock Down 1.2 %

TRUP traded down $0.41 during trading on Tuesday, reaching $34.04. 223,608 shares of the stock traded hands, compared to its average volume of 648,967. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The stock's 50-day simple moving average is $39.33 and its two-hundred day simple moving average is $46.14. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of -148.05, a price-to-earnings-growth ratio of 6.02 and a beta of 1.66.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on TRUP shares. Piper Sandler cut their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Stifel Nicolaus reduced their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $46.60.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.